Cerebellar Hemangioblastoma in A Patient With Von Hippel-Lindau Syndrome

Authors

  • Julia Brasileiro de Faria Cavalcante Department of Neurosurgery, Hospital of Neurology Santa Mônica, Goiânia, GO, Brazil Author
  • Pedro Nogarotto Cembraneli Department of Neurosurgery, Hospital of Neurology Santa Mônica, Goiânia, GO, Brazil Author
  • Renata Brasileiro de Faria Cavalcante Department of Neurosurgery, Hospital of Neurology Santa Mônica, Goiânia, GO, Brazil Author
  • José Edison da Silva Cavalcante Department of Neurosurgery, Hospital of Neurology Santa Mônica, Goiânia, GO, Brazil Author
  • Alessandro Fonseca Cardoso Department of Neurosurgery, Hospital of Neurology Santa Mônica, Goiânia, GO, Brazil Author
  • Chrystiano Fonseca Cardoso Department of Neurosurgery, Hospital of Neurology Santa Mônica, Goiânia, GO, Brazil Author
  • Italo Nogarotto Cembraneli Departament of Medicine, University Center of Mineiros, Mineiros, GO, Brazil Author
  • Leonardo Taveira Lopes Department of Radiology, Hospital of Neurology Santa Mônica, Goiânia, GO, Brazil Author

DOI:

https://doi.org/10.33425/2692-7918.1081

Abstract

Von Hippel-Lindau syndrome (VHL) is an autosomal dominant hereditary disease characterized by a variety of benign/malignant tumors, mainly hemangioblastomas, renal, pancreatic, and hepatic alterations, as well as pheochromocytoma. The disease is associated with high morbidity and mortality and can affect multiple family members. Due to the potential for serious complications and psychosocial impacts, early diagnosis is crucial for monitoring tumor lesions, multidisciplinary treatment, and appropriate genetic counseling.

Published

2025-07-28

Issue

Section

Articles